DNA Nanomachines Detect Lung Cancer Mutations Without Target Amplification
Researchers have developed molecular filler-enhanced DNA nanomachines that quantify circulating tumor DNA mutations directly from plasma without enzymatic amplification.
Researchers have developed molecular filler-enhanced DNA nanomachines that quantify circulating tumor DNA mutations directly from plasma without enzymatic amplification.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.